Interaction of silver nanoparticles with HIV-1
By J. L. Elechiguerra, J. Burt, J. Morones, A. Camacho-Bragado, Xiao-Yun Gao, H. H. Lara, Miguel José Yacamán. Journal of Nanobiotechnology, 2005
1,714 citations recorded by the source corpus.
The interaction of nanoparticles with biomolecules and microorganisms is an expanding field of research. Within this field, an area that has been largely unexplored is the interaction of metal nanoparticles with viruses. In this work, we demonstrate that silver nanoparticles undergo a size-dependent interaction with HIV-1, with nanoparticles exclusively in the range of 1–10 nm attached to the virus. The regular spatial arrangement of the attached nanoparticles, the center-to-center distance between nanoparticles, and the fact that the exposed sulfur-bearing residues of the glycoprotein knobs would be attractive sites for nanoparticle interaction suggest that silver nanoparticles interact with the HIV-1 virus via preferential binding to the gp120 glycoprotein knobs. Due to this interaction, silver nanoparticles inhibit the virus from binding to host cells, as demonstrated in vitro.
Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health, Virology
View Paper: https://www.semanticscholar.org/paper/4ed8964c284782b8adf0b20eabdaeb529941cec3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- S. Galdiero
- H. H. Lara
- A. Falanga
- P. Asharani
- Catalina Marambio-Jones
- M. Ahamed
- Qilin Li
- N. V. Ayala-Nunez
Citations in the corpus
- Silver nanoparticles: Synthesis, medical applications and biosafety (2020, positive): “For example, AgNPs can bind to the glycoprotein knobs and inhibit the reverse transcriptase (RT) of HIV-1 and interact with the virus in size- and dose-dependent manner [169, 185].”
- Introduction to metallic nanoparticles (2010, positive): “demonstrated that silver nanoparticles undergo a size-dependent interaction with HIV-1, with particles exclusively in the range of 1–10 nm attached to the virus.[87] They further suggest that silver nanoparticles interact with the HIV-1 virus via preferential binding to the gp120 glycoprotein knobs.”
- Mode of antiviral action of silver nanoparticles against HIV-1 (2010, positive): “The observations previously made by STEM analysis support this idea, since silver nanoparticles were seen to bind protein structures distributed over the viral membrane [7] If silver nanoparticles do not bind to the V3 loop, then they might preferentially interact with the negative cavity of gp120 t”
- A review on green synthesis of silver nanoparticles and their applications (2017, neutral): “(Ahmed et al. 2015, Baram-Pinto et al. 2009, Elechiguerra et al. 2005, Lara et al. 2010, Lu et al. 2008, Rogers et al. 2008, Sun et al. 2008) Antifungal activity Ag-NPs have fungicidal and antifungal activity against Candida albicans, Candida krusei, Candida species, Candida glabrata, Trichophyton…”
- Silver Nanoparticles as Potential Antiviral Agents (2011, positive): “Elechiguerra et al. [37] were the first to describe the antiviral activity of metal nanoparticles, in fact, they found that silver nanoparticles undergo size-dependent interactions with HIV-1.”